Impact of suppressing retinoic acid-related orphan receptor gamma t (ROR)γt in ameliorating central nervous system autoimmunity
RC Winger, PW Lee, PK Nuro-Gyina… - Clinical & …, 2015 - academic.oup.com
Multiple sclerosis (MS) is an immune-mediated chronic central nervous system (CNS)
disease affecting more than 400 000 people in the United States. Myelin-reactive CD4 T …
disease affecting more than 400 000 people in the United States. Myelin-reactive CD4 T …
[HTML][HTML] Impact of suppressing retinoic acid-related orphan receptor gamma t (ROR) γt in ameliorating central nervous system autoimmunity
Y Yang, RC Winger, PW Lee… - Clinical and …, 2015 - ncbi.nlm.nih.gov
Multiple sclerosis (MS) is an immune-mediated chronic central nervous system (CNS)
disease affecting more than 400 000 people in the United States. Myelin-reactive CD4 T …
disease affecting more than 400 000 people in the United States. Myelin-reactive CD4 T …
Impact of suppressing retinoic acid‐related orphan receptor gamma t (ROR)γt in ameliorating central nervous system autoimmunity
Y Yang, RC Winger, PW Lee… - Clinical & …, 2015 - Wiley Online Library
M ultiple sclerosis (MS) is an immune‐mediated chronic central nervous system (CNS)
disease affecting more than 400 000 people in the United States. Myelin‐reactive CD 4 T …
disease affecting more than 400 000 people in the United States. Myelin‐reactive CD 4 T …
Impact of suppressing retinoic acid-related orphan receptor gamma t (ROR) γt in ameliorating central nervous system autoimmunity.
Y Yang, RC Winger, PW Lee… - Clinical & …, 2015 - search.ebscohost.com
Multiple sclerosis (MS) is an immune-mediated chronic central nervous system (CNS)
disease affecting more than 400 000 people in the United States. Myelin-reactive CD4 T …
disease affecting more than 400 000 people in the United States. Myelin-reactive CD4 T …
Impact of suppressing retinoic acid-related orphan receptor gamma t (ROR) γt in ameliorating central nervous system autoimmunity
Y Yang, RC Winger, PW Lee… - Clinical and …, 2015 - pubmed.ncbi.nlm.nih.gov
Multiple sclerosis (MS) is an immune-mediated chronic central nervous system (CNS)
disease affecting more than 400 000 people in the United States. Myelin-reactive CD4 T …
disease affecting more than 400 000 people in the United States. Myelin-reactive CD4 T …
Impact of suppressing retinoic acid-related orphan receptor gamma t (ROR) γt in ameliorating central nervous system autoimmunity
Y Yang, RC Winger, PW Lee… - Clinical and …, 2015 - ohiostate.elsevierpure.com
Multiple sclerosis (MS) is an immune-mediated chronic central nervous system (CNS)
disease affecting more than 400000 people in the United States. Myelin-reactive CD4 T cells …
disease affecting more than 400000 people in the United States. Myelin-reactive CD4 T cells …
Impact of suppressing retinoic acid‐related orphan receptor gamma t (ROR)γt in ameliorating central nervous system autoimmunity
Y Yang, RC Winger, PW Lee, PK Nuro‐Gyina… - Clinical & Experimental …, 2014 - infona.pl
M ultiple sclerosis (MS) is an immune‐mediated chronic central nervous system (CNS)
disease affecting more than 400 000 people in the United States. Myelin‐reactive CD 4 T …
disease affecting more than 400 000 people in the United States. Myelin‐reactive CD 4 T …
Impact of suppressing retinoic acid-related orphan receptor gamma t (ROR) γt in ameliorating central nervous system autoimmunity.
Y Yang, RC Winger, PW Lee… - Clinical and …, 2015 - europepmc.org
Multiple sclerosis (MS) is an immune-mediated chronic central nervous system (CNS)
disease affecting more than 400 000 people in the United States. Myelin-reactive CD4 T …
disease affecting more than 400 000 people in the United States. Myelin-reactive CD4 T …